Anti-EXOC2 抗体 [EPR9420]
Anti-EXOC2 antibody [EPR9420]
- RabMAb
- Recombinant
- 詳細を見る
5
(1 Review)
|
(5 Publications)
Rabbit Recombinant Monoclonal EXOC2 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat samples. Cited in 5 publications.
別名を表示する
SEC5, SEC5L1, EXOC2, Exocyst complex component 2, Exocyst complex component Sec5
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-EXOC2 antibody [EPR9420] (AB140620)
Intracellular flow cytometric analysis of permeabilized BxPC-3 cells labelling EXOC2 with ab140620 at 1/10 dilution (red) or a Rabbit IgG negative control (green).
- WB
Lab
Western blot - Anti-EXOC2 antibody [EPR9420] (AB140620)
Lanes 1- 4 : Merged signal (red and green). Green - ab140620 observed at 104 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab140620 was shown to react with EXOC2 in wild-type HeLa cells in western blot. The band observed in CRISPR/Cas9 edited cell line ab265839 (CRISPR/Cas9 edited cell lysate ab257944) lane below 104kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and EXOC2 CRISPR/Cas9 edited HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab140620 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-EXOC2 antibody [EPR9420] (ab140620) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
EXOC2 CRISPR/Cas9 edited HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human EXOC2 knockout HeLa cell line (<a href='/products/cell-lines/human-exoc2-knockout-hela-cell-line-ab265839'>ab265839</a>)
Lane 3:
SH-SY5Y cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Predicted band size: 104 kDa
Observed band size: 104 kDa
false
- WB
Lab
Western blot - Anti-EXOC2 antibody [EPR9420] (AB140620)
Lanes 1- 4 : Merged signal (red and green). Green - ab140620 observed at 104 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab140620 was shown to react with EXOC2 in wild-type HeLa cells in western blot. The band observed in knockout cell line ab265839 (knockout cell lysate ab257944) lane below 104kDa may represent truncated forms and cleaved fragments. This has not been investigated further. Wild-type HeLa and EXOC2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab140620 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-EXOC2 antibody [EPR9420] (ab140620) at 1000 µg
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
EXOC2 knockout HeLa cell lysate at 20 µg
Lane 3:
SH-SY5Y cell lysate at 20 µg
Lane 4:
Daudi cell lysate at 20 µg
Predicted band size: 104 kDa
Observed band size: 104 kDa
false
- WB
Unknown
Western blot - Anti-EXOC2 antibody [EPR9420] (AB140620)
All lanes:
Western blot - Anti-EXOC2 antibody [EPR9420] (ab140620) at 1/1000 dilution
Lane 1:
BxPC-3 cell lysate at 10 µg
Lane 2:
Human placenta tissue lysate at 10 µg
Lane 3:
Fetal brain tissue lysate at 10 µg
Lane 4:
SH-SY5Y cell lysate at 10 µg
Predicted band size: 104 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-EXOC2 antibody [EPR9420] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製度
バッファー組成
出荷温度
短期保存温度
長期保存温度
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
EXOC2 acts as a fundamental part of the exocyst complex which comprises eight proteins. This complex orchestrates vesicle targeting and tethering during exocytosis a process essential for maintaining cell surface area and membrane protein composition. Unlike other vesicle trafficking complexes the exocyst shows significant specificity for certain vesicles and localization contributing to the precision of membrane-associated functions.
Pathways
EXOC2 joins key pathways like the insulin signaling pathway and the regulation of actin cytoskeleton. In the insulin signaling pathway EXOC2 integrates with components such as the protein Rab11 to mediate glucose transporter vesicle trafficking impacting glucose uptake. In the regulation of the actin cytoskeleton it interacts with actin-related proteins to influence cell shape and motility.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (5)
Recent publications for all applications. Explore the full list and refine your search
Nature cancer 6:1714-1733 PubMed40877413
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 43:114375 PubMed38935506
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 15:3120 PubMed38600106
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 217: PubMed32639540
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 10:522 PubMed31191298
2019
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com